ELUT · Elutia
The AI's read
A share-price move alone does not show that Elutia's sales, products, or finances changed. The article gives no reason for the move, so it adds no new information about the business.
Elutia shares rose about 17% to $0.94 after hours, but the article reports no business update or reason for the move. It does not change the company's outlook.
A share-price move alone does not show that Elutia's sales, products, or finances changed. The article gives no reason for the move, so it adds no new information about the business.
Intelligent Bio Solutions shares rose about 10% to $1.85 after hours, but the article reports no business update or reason for the move. It does not change the company's outlook.
Sunshine Biopharma shares rose about 9% to $0.75 after hours, but the article reports no business update or reason for the move. It does not change the company's outlook.
NewGenIvf Group shares rose about 9% to $0.11 after hours, but the article reports no business update or reason for the move. It does not change the company's outlook.
NextCure shares rose about 7% to $5.30 after hours, but the article reports no business update or reason for the move. It does not change the company's outlook.
Edesa Biotech shares rose about 6% to $4.24 after hours, but the article reports no business update or reason for the move. It does not change the company's outlook.
Follow Elutia (ELUT) free. When we publish a story about it, you get the plain-English explanation as an alert.
Get alerts for ELUT